{
  "id": "603bc2b61cb411341a00015b",
  "type": "yesno",
  "question": "Is autism thought to be related to the  Arginine Vasopressin Peptide (AVP)?",
  "ideal_answer": "Differences in vasopressin levels in individuals suffering from the autism spectrum disorders have been demonstrated.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/15098001",
    "http://www.ncbi.nlm.nih.gov/pubmed/28283809",
    "http://www.ncbi.nlm.nih.gov/pubmed/21453499",
    "http://www.ncbi.nlm.nih.gov/pubmed/32650534",
    "http://www.ncbi.nlm.nih.gov/pubmed/32341146",
    "http://www.ncbi.nlm.nih.gov/pubmed/31043522",
    "http://www.ncbi.nlm.nih.gov/pubmed/28258508",
    "http://www.ncbi.nlm.nih.gov/pubmed/26200852",
    "http://www.ncbi.nlm.nih.gov/pubmed/31571878",
    "http://www.ncbi.nlm.nih.gov/pubmed/21150165",
    "http://www.ncbi.nlm.nih.gov/pubmed/23413037",
    "http://www.ncbi.nlm.nih.gov/pubmed/27974283",
    "http://www.ncbi.nlm.nih.gov/pubmed/17174726"
  ],
  "snippets": [
    {
      "text": "However, we recently found that cerebrospinal fluid (CSF) concentration of the \"social\" neuropeptide arginine vasopressin (AVP) is significantly lower in pediatric ASD cases vs. controls.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32341146",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "A large number of controlled trials demonstrated that exogenous oxytocin or arginine-vasopressin administration can mitigate social behavior impairment in ASD",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32650534",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "An accumulating body of evidence indicates a tight relationship between the endocrine system and abnormal social behavior. Two evolutionarily conserved hypothalamic peptides, oxytocin and arginine-vasopressin, because of their extensively documented function in supporting and regulating affiliative and socio-emotional responses, have attracted great interest for their critical implications for autism spectrum disorders (ASD",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32650534",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Preclinical research suggests that arginine vasopressin (AVP), a neuropeptide involved in promoting mammalian social behaviors, may be a possible treatment for ASD. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31043522",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "These preliminary findings suggest that AVP has potential for treating social impairments in children with ASD.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31043522",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The aim of this study was a systematic review of previous studies regarding the differences in OXT and vasopressin levels in ASD and neurotypical persons",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31571878",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Differences in oxytocin and vasopressin levels in individuals suffering from the autism spectrum disorders vs general population - a systematic review.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31571878",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "The contribution of oxytocin and vasopressin to mammalian social behavior: potential role in autism spectrum disorder.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21150165",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Although the mechanisms underlying its etiology and manifestations are poorly understood, several lines of evidence from rodent and human studies suggest involvement of the evolutionarily highly-conserved oxytocin (OXT) and arginine-vasopressin (AVP), as these neuropeptides modulate various aspects of mammalian social behavior.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28283809",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "linical research suggests that arginine vasopressin (AVP), a neuropeptide involved in promoting mammalian social behaviors, may be a possible treatment for ASD. Using",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31043522",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Previous results suggest that OXT and arginine vasopressin (AVP) may play a role in the etiopathogenesis of ASD",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974283",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "There has been intensified interest in the neuropeptides oxytocin (OT) and arginine vasopressin (AVP) in autism spectrum disorders (ASD) given their role in affiliative and social behavior in animals, positive results of treatment studies using OT, and findings that genetic polymorphisms in the AVP-OT pathway are present in individuals with ASD",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23413037",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND: Arginine vasopressin (AVP) has been hypothesized to play a role in aetiology of autism based on a demonstrated involvement in the regulation of social",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21453499",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Preclinical research suggests that arginine vasopressin (AVP), a neuropeptide involved in promoting mammalian social behaviors, may be a possible treatment for ASD.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31043522",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "There has been intensified interest in the neuropeptides oxytocin (OT) and arginine vasopressin (AVP) in autism spectrum disorders (ASD) given their role in affiliative and social behavior in animals, positive results of treatment studies using OT, and findings that genetic polymorphisms in the AVP-OT pathway are present in individuals with ASD.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23413037",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We therefore hypothesized that AVP signaling deficits may contribute to social impairments in children with autism spectrum disorder (ASD).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26200852",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Given the emerging biological, animal model, and now genetic data, AVPR1a and genes in the AVP system remain strong candidates for involvement in autism susceptibility and deserve continued scrutiny.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15098001",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The behavioral effects of AVP are mediated through the AVP receptor 1a (AVPR1a), making the AVPR1a gene a reasonable candidate for autism susceptibility.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15098001",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Dysfunction of brain-derived arginine-vasopressin (AVP) systems may be involved in the etiology of autism spectrum disorder (ASD).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28258508",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "These results strongly suggest that changes in structure and FC in brain regions containing AVP may be involved in the etiology of autism.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28258508",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Arginine Vasopressin Is a Blood-Based Biomarker of Social Functioning in Children with Autism.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26200852",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "These findings also suggest that AVP biology may be a promising therapeutic target by which to improve social cognition in individuals with ASD.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26200852",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Genes Related to Oxytocin and Arginine-Vasopressin Pathways: Associations with Autism Spectrum Disorders.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28283809",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "BACKGROUND: Dysregulation of the vasopressin (AVP) system has been implicated in the pathogenesis of autistic spectrum dis",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17174726",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}